top of page

Our Three Client Segments:

Big Pharma & Large Service Providers
Company-wide C> mid-long term Strategy, Roadmaps and Implementation including New Modalities assessment, Market Sizing, BD Opportunities and Integration Requirements.

Start-ups, Small & Mid-Sized Biotech
C> process reliability and scale-up, evaluation of key sourcing options including internal facility, greenfield and CDMO sourcing.

Private Equity & Venture Capital
Due Diligence and Business Case for a next-generation C> platform, including technical & organizational evaluation, COGS and market assessment.
Recent C> Clients

Editas (Gene Editing)

Kiadis (NK Cells)

BioNTech (mRNA)

Sarepta (Viral Vectors)

GreenLight (mRNA)

Touchlight (Syn. Plasmid)

Lonza (Cell Therapy)

Cytiva (Next-Gen C>)

Sanofi (Viral Vectors)

Alexion (Cell and Gene)

Novartis (Cell and Gene)

Roche (Viral Vectors)

Gimv (Undisclosed)

Baupost (Undisclosed)
bottom of page